参考文献
(在框内滑动手指即可浏览)
[1] McDermott MT. Hyperthyroidism[J]. Ann Intern Med, 2020, 172(7): Itc49-Itc64.
[2] Bahn.RS. 格雷夫斯病-临床实践指南[M].北京: 北京大学医学出版社, 2016: 5-6.
[3] 王深明. 甲状腺功能亢进的分类和病因[J]. 中国实用外科杂志, 2006, 26(7): 487-489.
[4] 中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组. 中国甲状腺疾病诊治指南-甲状腺功能亢进症[J]. 中华内科杂志, 2007, 46(10): 876-882.
[5] Burch HB, Cooper DS. Management of Graves Disease: A Review[J]. JAMA, 2015, 314(23): 2544-2554.
[6] De Leo S, Lee SY, Braverman LE. Hyperthyroidism[J]. The Lancet, 2016, 388(10047): 906-918.
[7] Shan ZY, Chen LL, Lian XL, et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: A cross-sectional study in 10 cities [J]. Thyroid, 2016, 28(8): 1125-1130.
[8] Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis[J]. Thyroid, 2016, 26(10): 1343-1421.
[9] 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会. 甲状腺功能亢进症基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2019, 18(12): 1118-1128.
[10] 李晓曦. 实验室检查在甲状腺结节诊治中的合理选择与评价[J]. 中国实用外科杂志, 2015, 35(6): 629-633.
[11] 中华医学会内分泌学分会, 中华医学会外科学分会内分泌外科学组, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南[J]. 中华核医学与分子影像杂志, 2013, 22(2): 96-115.
[12] 中华医学会核医学分会编写委员会. 131I治疗格雷夫斯甲亢指南(2013版)[J]. 中华核医学与分子影像杂志, 2013, 33(2): 83-94.
[13] Hamilton LOW, Lim AE, Clark LJ. Total thyroidectomy for Graves' disease-what do our patients think? A qualitative cohort study to evaluate the surgical management of Graves' disease[J]. Surgeon, 2020, 18(4): 193-196.
[14] Minuto MN, Reina S, Monti E, et al. Morbidity following thyroid surgery: acceptable rates and how to manage complicated patients[J]. J Endocrinol Invest, 2019, 42(11): 1291-1297.
[15] Akamizu T. Thyroid Storm: A Japanese Perspective[J]. Thyroid, 2018, 28(1): 32-40.
[16] Erbil Y, Ozluk Y, Giris M, et al. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease[J]. J Clin Endocrinol Metab, 2007, 92(6): 2182-2189.
[17] 付言涛, 孙辉. 甲状腺功能亢进病人围手术期碘准备临床进展[J]. 中国实用外科杂志, 2018, 38(6): 630-634.
[18] 朱精强, 李志辉, 魏涛, 等. 甲状腺功能衰竭法在甲状腺功能亢进手术前准备的前瞻性研究[J]. 四川大学学报(医学版), 2007, 38(5): 866-870.
[19] 朱精强, 刘枫. 甲状腺功能亢进的外科治疗之我见[J]. 医学与哲学, 2013, 34(9): 22-30.
[20] Corvilain B, Hamy A, Brunaud L, et al. Treatment of adult Graves' disease[J]. Ann Endocrinol (Paris), 2018, 79(6): 618-635.
[21] Yabuta T, Ito Y, Hirokawa M, et al. Preoperative administration of excess iodide increases thyroid volume of patients with Graves' disease[J]. Endocr J, 2009, 56(3): 371-375.
[22] Shinall MC, Jr., Broome JT, Baker A, et al. Is potassium iodide solution necessary before total thyroidectomy for Graves disease?[J]. Ann Surg Oncol, 2013, 20(9): 2964-2967.
[23] Hassan I, Danila R, Aljabri H, et al. Is rapid preparation for thyroidectomy in severe Graves' disease beneficial? The relationship between clinical and immunohistochemical aspects[J]. Endocrine, 2008, 33(2): 189-195.
[24] Kaur S, Parr JH, Ramsay ID, et al. Effect of preoperative iodine in patients with Graves' disease controlled with antithyroid drugs and thyroxine[J]. Ann R Coll Surg Engl, 1988, 70(3): 123-127.
[25] Tsai CH, Yang PS, Lee JJ, et al. Effects of Preoperative Iodine Administration on Thyroidectomy for Hyperthyroidism: A Systematic Review and Meta-analysis[J]. Otolaryngol Head Neck Surg, 2019, 160(6): 993-1002.
[26] 梁青壮, 易辛, 李朋, 等. 甲状腺功能亢进患者围手术期不服碘剂的探讨[J]. 中华普通外科杂志, 2019, 34(9): 810-811.
[27] Ali A, Debono M, Balasubramanian SP. Outcomes After Urgent Thyroidectomy Following Rapid Control of Thyrotoxicosis in Graves' Disease are Similar to Those After Elective Surgery in Well-Controlled Disease[J]. World J Surg, 2019, 43(12): 3051-3058.
[28] 卢秀波, 王庆兆, 张静, 等. 地塞米松在原发性甲状腺功能亢进症围手术期的应用[J]. 郑州大学学报(医学版), 2002, 37(4): 417-419.
[29] Bobanga ID, McHenry CR. Treatment of patients with Graves' disease and the appropriate extent of thyroidectomy[J]. Best Pract Res Clin Endocrinol Metab, 2019, 33(4): 1-11.
[30] Sugino K, Nagahama M, Kitagawa W, et al. Change of surgical strategy for Graves' disease from subtotal thyroidectomy to total thyroidectomy: a single institutional experience[J]. Endocr J, 2019, 66(2): 181-186.
[31] Sung TY, Lee YM, Yoon JH, et al. Long-Term Effect of Surgery in Graves' Disease: 20 Years Experience in a Single Institution[J]. Int J Endocrinol, 2015, 2015: 1-6.
[32] Ylli D, Klubo-Gwiezdzinska J, Wartofsky L. Thyroid emergencies[J]. Pol Arch Intern Med, 2019, 129(7-8): 526-534.
[33] Klubo-Gwiezdzinska J, Wartofsky L. Thyroid emergencies[J]. Med Clin North Am, 2012, 96(2): 385-403.
[34] Kwon H, Kim JK, Lim W, et al. Increased risk of postoperative complications after total thyroidectomy with Graves' disease[J]. Head Neck, 2019, 41(2): 281-285.
[35] 中国医师协会外科医师分会甲状腺外科医师委员会, 中华医学会外科学分会甲状腺及代谢外科学组, 中国研究型医院学会甲状腺疾病专业委员会. 甲状腺围手术期甲状旁腺功能保护指南(2018版)[J]. 中国实用外科杂志, 2018, 38(10): 1108-1113.
[36] Fan C, Zhou X, Su G, et al. Risk factors for neck hematoma requiring surgical re-intervention after thyroidectomy: a systematic review and meta-analysis[J]. BMC Surg, 2019, 19(1): 98.
[37] 中华医学会内分泌学分会. 成人甲状腺功能减退症诊治指南[J]. 中华内分泌代谢杂志, 2017, 33(2): 167-180.